Last $10.27 USD
Change Today -0.08 / -0.77%
Volume 135.1K
HRTX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Barry D. Quart Pharm.D.

Chief Executive Officer and Director, Heron Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 27 board members in 4 different organizations across 7 different industries.

See Board Relationships
57$8,256,214
As of Fiscal Year 2013

Background*

Dr. Barry D. Quart, Pharm.D., has been the Chief Executive Officer of Heron Therapeutics, Inc. (Alternate Name, AP Pharma Inc.) since May 2, 2013. Dr. Quart serves as the Clinical Advisor of Napo Pharmaceuticals, Inc. He served as the Chief Executive Officer and President of Ardea Biosciences, Inc. since December 21, 2006, which was acquired by AstraZeneca PLC in June 2012. He served as General Manager for Americas Region, Kodak's Business Solutions and Services of Eastman ...

Read Full Background

Corporate Headquarters*

123 Saginaw Drive
Redwood City, California 94063

United States

Phone: 650-366-2626
Fax: --

Board Members Memberships*

Director
2002-2006
Clinical Advisor
2006-N/A
Former Chief Executive Officer, President and Executive Director
2006-Present
Director
2007-Present
Director
2007-N/A
Director, Member of Audit Committee and Member of Compensation Committee
2012-Present
Chief Executive Officer and Director

Education*

Doctorate
University of California-San Francisco

Other Affiliations*

Annual Compensation*

Salary$349,327
Total Annual Compensation$349,327

Stock Options*

All Other Compensation$6,000
Exercisable Options74,182
Unexercisable Options1,125,000
Unexercisable Options Value$2,025,000
Total Value of Options$2,025,000
Total Number of Options1,199,182

Total Compensation*

Total Annual Cash Compensation$630,964
Total Short Term Compensation$349,327
Other Long Term Compensation$6,000
Total Calculated Compensation$8,256,214
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HRTX:US $10.27 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HERON THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.